Etiology and Pathogenesis of Systemic Lupus Erythematosus

Kelley's Textbook of Rheumatology: Volume 1-2, Ninth Edition

Volumn 2, Issue , 2012, Pages 1269-1282

  Crow, Mary K ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85167739202     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1738-9.00079-7     Document Type: Chapter

References (86)

1. JB Harley, ME Alarcon-Riquelme, LA Criswell, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40(2), 204-210
2. G Hom, RR Graham, B Modrek, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358(9), 900-909
3. Y Deng and BP Tsao (2010) Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 6(12), 683-692
4. P Price, C Witt, R Allcock, et al. (1999) The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 167 257-274
5. D Mevorach (2010) Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Apoptosis 15(9), 1114-1123
6. DM Santer, BE Hall, TC George, et al. (2010) C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. J Immunol 185(8), 4738-4749
7. G Rice, WG Newman, J Dean, et al. (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 80(4), 811-815
8. MA Lee-Kirsch, M Gong, D Chowdhury, et al. (2007) Mutations in the gene encoding the 3’-5’ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39(9), 1065-1067
9. GI Rice, J Bond, A Asipu, et al. (2009) Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41(7), 829-832
10. DB Stetson, JS Ko, T Heidmann and R Medzhitov (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134(4), 587-598
11. B Namjou, PH Kothari, JA Kelly, et al. (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12(4), 270-279
12. TB Niewold, JA Kelly, MH Flesch, et al. (2008) Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 58(8), 2481-2487
13. SN Kariuki, BS Franek, AA Kumar, et al. (2010) Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther 12(4), R151
14. PS Ramos, AH Williams, JT Ziegler, et al. (2011) Genetic analyses of interferon pathway-related genes reveals multiple new loci associated with systemic lupus erythematosus (SLE). Arthritis Rheum 63 2049-2057
15. DL Boone, EE Turer, EG Lee, et al. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5(10), 1052-1060
16. RR Graham, W Ortmann, P Rodine, et al. (2007) Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 15(8), 823-830
17. K Liu, QZ Li, AM Delgado-Vega, et al. (2009) Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest 119(4), 911-923
18. R Salloum, BS Franek, SN Kariuki, et al. (2010) Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum 62(2), 553-561
19. SA Chung, KE Taylor, RR Graham, et al. (2011) Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 7(3), e1001323
20. KE Taylor, SA Chung, RR Graham, et al. (2011) Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet 7(2), e1001311
21. JF Cohen-Solal, V Jeganathan, L Hill, et al. (2008) Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus 17(6), 528-532
22. RH Scofield, GR Bruner, B Namjou, et al. (2008) Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58(8), 2511-2517
23. JA Deane, P Pisitkun, RS Barrett, et al. (2007) Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27(5), 801-810
24. BM Javierre, AF Fernandez, J Richter, et al. (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20(2), 170-179
25. KH Costenbader, D Feskanich, MJ Stampfer and EW Karlson (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4), 1251-1262
26. J Castañeda, P Genzor and A Bortvin (2011) piRNAs, transposon silencing, and germline genome integrity. Mutat Res 714 95-104
27. GS Alarcon, J Calvo-Alen, G McGwin Jr, et al. (2006) Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 65(9), 1168-1174
28. UY Moon, SJ Park, ST Oh, et al. (2004) Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 6(4), R295-302
29. BD Poole, AK Templeton, JM Guthridge, et al. (2009) Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev 8(4), 337-342
30. AL Peters, LL Stunz, DK Meyerholz, et al. (2010) Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice. J Immunol 185(7), 4053-4062
31. P Yadav, H Tran, R Ebegbe, et al. (2011) Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One 6(1), e14488
32. I Kang, T Quan, H Nolasco, et al. (2004) Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172(2), 1287-1294
33. KH Costenbader, DJ Kim, J Peerzada, et al. (2004) Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 50(3), 849-857
34. G Gorelik, JY Fang, A Wu, et al. (2007) Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 179(8), 5553-5563
35. L Bennett, AK Palucka, E Arce, et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6), 711-723
36. EC Baechler, FM Batliwalla, G Karypis, et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100(5), 2610-2615
37. MK Crow, KA Kirou and J Wohlgemuth (2003) Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36(8), 481-490
38. T Lovgren, ML Eloranta, U Bave, et al. (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50(6), 1861-1872
39. U Bave, M Magnusson, ML Eloranta, et al. (2003) Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol 171(6), 3296-3302
40. FJ Barrat, T Meeker, J Gregorio, et al. (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202(8), 1131-1139
41. KA Kirou, C Lee, S George, et al. (2005) Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52(5), 1491-1503
42. SR Christensen, J Shupe, K Nickerson, et al. (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25(3), 417-428
43. KM Nickerson, SR Christensen, J Shupe, et al. (2010) TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 184(4), 1840-1848
44. P Duffau, J Seneschal, C Nicco, et al. (2010) Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med 2(47), 47ra63
45. MF Denny, S Yalavarthi, W Zhao, et al. (2010) A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 184(6), 3284-3297
46. D Lindau, V Ronnefarth, A Erbacher, et al. (2011) Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Eur J Immunol 41(3), 669-681
47. GS Garcia-Romo, S Caielli, B Vega, et al. (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3(73), 73ra20
48. R Lande, D Ganguly, V Facchinetti, et al. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3(73), 73ra19
49. E Villanueva, S Yalavarthi, CC Berthier, et al. (2011) Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 187(1), 538-552
50. AJ Ullal, CF Reich 3rd, M Clowse, et al. (2011) Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun 36(3-4), 173-180
51. B Gullstrand, U Martensson, G Sturfelt, et al. (2009) Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol 156(2), 303-311
52. A Johnston, GR Auda, MA Kerr, et al. (1992) Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates. Mol Immunol 29(5), 659-665
53. JC Crispin, VC Kyttaris, C Terhorst and GC Tsokos (2010) T cells as therapeutic targets in SLE. Nat Rev Rheumatol 6(6), 317-325
54. R Ettinger, GP Sims, R Robbins, et al. (2007) IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol 178(5), 2872-2882
55. MP Nambiar, CU Fisher, VG Warke, et al. (2003) Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum 48(7), 1948-1955
56. D Fernandez, E Bonilla, N Mirza, et al. (2006) Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum 54(9), 2983-2988
57. B Richardson (2003) DNA methylation and autoimmune disease. Clin Immunol 109(1), 72-79
58. N Simpson, PA Gatenby, A Wilson, et al. (2010) Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 62(1), 234-244
59. YS Choi, R Kageyama, D Eto, et al. (2011) ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34(6), 932-946
60. EF McKinney, PA Lyons, EJ Carr, et al. (2010) A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 16(5), 586-591
61. Q Xing, B Wang, H Su, et al. (2012) Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int 32(4), 949-958
62. LA Lieberman and GC Tsokos (2010) The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J Biomed Biotechnol 2010 740619
63. LL Ritterhouse, SR Crowe, TB Niewold, et al. (2011) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70 1569-1574
64. L Menard, D Saadoun, I Isnardi, et al. (2011) The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest 121 3635-3644
65. F Flores-Borja, PS Kabouridis, EC Jury, et al. (2005) Decreased LYN expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 52(12), 3955-3965
66. R Lu, GS Vidal, JA Kelly, AM Delgado-Vega, et al. (2009) Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 10(5), 397-403
67. X Li, J Wu, RH Carter, JC Edberg, et al. (2003) A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 48(11), 3242-3252
68. MC Blank, RN Stefanescu, E Masuda, et al. (2005) Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 117(2-3), 220-227
69. HM Horton, SY Chu, EC Ortiz, et al. (2011) Antibody-mediated coengagement of FcgammaRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol 186(7), 4223-4233
70. F Hiepe, T Dorner, AE Hauser, et al. (2011) Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 7(3), 170-178
71. AM Jacobi, H Mei, BF Hoyer, et al. (2010) HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann Rheum Dis 69(1), 305-308
72. JW Dieker, CC Van Bavel, G Riemekasten, et al. (2006) The binding of lupus-derived autoantibodies to the C-terminal peptide (83–119) of the major SmD1 autoantigen can be mediated by double-stranded DNA and nucleosomes. Ann Rheum Dis 65(11), 1525-1528
73. S Langer, D Langnickel, P Enghard, et al. (2007) The systemic and SmD183–119-autoantigen-specific cytokine memory of Th cells in SLE patients. Rheumatology (Oxford) 46(2), 238-245
74. MR Arbuckle, MT McClain, MV Rubertone, et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16), 1526-1533
75. C Jiang, US Deshmukh, F Gaskin, et al. (2010) Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J Immunol 184(2), 1085-1091
76. C Bigler, M Schaller, I Perahud, et al. (2009) Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J Immunol 183(5), 3512-3521
77. Y Chen, S Khanna, CS Goodyear, et al. (2009) Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 183(2), 1346-1359
78. LA DeGiorgio, KN Konstantinov, SC Lee, et al. (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7(11), 1189-1193
79. JH Reed, RM Clancy, AW Purcell, et al. (2011) β2-Glycoprotein I and protection from anti-SSA/Ro60-associated cardiac manifestations of neonatal lupus. J Immunol 187(1), 520-526
80. G Girardi, J Berman, P Redecha, et al. (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112(11), 1644-1654
81. R Bethunaickan, CC Berthier, M Ramanujam, et al. (2011) A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. J Immunol 186(8), 4994-5003
82. A Triantafyllopoulou, CW Franzke, SV Seshan, et al. (2010) Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A 107(7), 3012-3017
83. P Hopkins, HM Belmont, J Buyon, et al. (1988) Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum 31(5), 632-641
84. MJ Kaplan (2009) Premature vascular damage in systemic lupus erythematosus. Autoimmunity 42(7), 580-586
85. M McMahon, J Grossman, B Skaggs, et al. (2009) Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum 60(8), 2428-2437
86. CM Magro, JC Poe, C Kim, et al. (2011) Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome. Am J Clin Pathol 135(4), 599-610